Evoke Pharma (NASDAQ:EVOK) Stock Passes Below 200 Day Moving Average of $0.93

Shares of Evoke Pharma, Inc. (NASDAQ:EVOK) passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.93 and traded as low as $0.44. Evoke Pharma shares last traded at $0.55, with a volume of 19,055 shares traded.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on shares of Evoke Pharma in a research report on Thursday. They issued a “sell” rating on the stock.

Evoke Pharma Price Performance

The firm has a market cap of $4.05 million, a PE ratio of -0.21 and a beta of 0.22. The company has a 50 day simple moving average of $0.62 and a 200-day simple moving average of $0.93.

Evoke Pharma (NASDAQ:EVOK) last issued its earnings results on Thursday, March 14th. The specialty pharmaceutical company reported ($0.59) earnings per share (EPS) for the quarter. The firm had revenue of $1.68 million during the quarter. Evoke Pharma had a negative return on equity of 517.99% and a negative net margin of 150.43%.

Evoke Pharma Company Profile

Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.